Your browser is no longer supported. Please, upgrade your browser.
Settings
NVS Novartis AG daily Stock Chart
NVS [NYSE]
Novartis AG
Index- P/E14.11 EPS (ttm)5.38 Insider Own9.30% Shs Outstand2.61B Perf Week-6.25%
Market Cap197.95B Forward P/E13.52 EPS next Y5.61 Insider Trans-0.54% Shs Float2.51B Perf Month-9.29%
Income12.61B PEG2.55 EPS next Q1.18 Inst Own11.90% Short Float0.11% Perf Quarter-4.06%
Sales53.17B P/S3.72 EPS this Y66.90% Inst Trans-0.08% Short Ratio1.03 Perf Half Y-1.74%
Book/sh34.03 P/B2.23 EPS next Y8.88% ROA8.90% Target Price97.00 Perf Year8.80%
Cash/sh6.12 P/C12.40 EPS next 5Y5.53% ROE16.60% 52W Range64.76 - 86.27 Perf YTD-1.25%
Dividend2.83 P/FCF35.78 EPS past 5Y7.70% ROI6.30% 52W High-12.02% Beta0.69
Dividend %3.73% Quick Ratio1.00 Sales past 5Y0.20% Gross Margin67.90% 52W Low17.20% ATR1.18
Employees125161 Current Ratio1.20 Sales Q/Q3.80% Oper. Margin15.40% RSI (14)25.21 Volatility1.79% 1.09%
OptionableYes Debt/Eq0.41 EPS Q/Q-37.10% Profit Margin23.70% Rel Volume3.31 Prev Close75.40
ShortableYes LT Debt/Eq0.29 EarningsApr 24 BMO Payout54.10% Avg Volume2.79M Price75.90
Recom1.00 SMA20-8.11% SMA50-7.25% SMA200-2.34% Volume8,824,100 Change0.66%
Apr-10-19Downgrade Morgan Stanley Equal-Weight → Underweight
Jan-02-19Downgrade JP Morgan Neutral → Underweight
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Underperform → Buy
May-29-18Downgrade HSBC Securities Buy → Hold
May-25-18Upgrade Credit Suisse Underperform → Neutral
Jan-25-18Reiterated Leerink Partners Outperform $93 → $100
Dec-06-17Downgrade BofA/Merrill Neutral → Underperform
Jul-26-17Upgrade Morgan Stanley Underweight → Overweight
Jul-05-17Downgrade Credit Suisse Neutral → Underperform
Mar-09-17Initiated Liberum Buy
Mar-08-17Upgrade Societe Generale Hold → Buy
Mar-07-17Downgrade Exane BNP Paribas Neutral → Underperform
Jan-11-17Downgrade Credit Suisse Outperform → Neutral
Nov-10-16Upgrade Argus Hold → Buy
Oct-10-16Reiterated Chardan Capital Markets Buy $95 → $92
Sep-20-16Initiated Chardan Capital Markets Buy $95
Apr-12-16Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-23-16Downgrade Leerink Partners Outperform → Mkt Perform
Apr-24-19 05:47AM  Novartis: 1Q Earnings Snapshot Associated Press
02:35AM  Novartis boosts 2019 outlook on rising Cosentyx, Entresto sales Reuters
02:32AM  Novartis upgrades 2019 profit guidance on strong sales growth Financial Times
01:55AM  Novartis boosts 2019 outlook on rising Cosentyx, Entresto sales Reuters
12:59AM  StockBeat - Elliott Effect Lifts SAP, as Softbank Bets on Wirecard Investing.com
Apr-23-19 06:38PM  Medicare offers to partially raise payment for cancer CAR-Ts Reuters
10:11AM  Health-care earnings: Medicare for all looms large MarketWatch
Apr-22-19 04:15PM  A Second Baby Died In A Gene Therapy Study Slugging This Biotech Stock Investor's Business Daily
05:55AM  Pfizer Stock Suffers From an Underappreciated Drugs Pipeline InvestorPlace
Apr-19-19 08:21PM  Second death in Novartis gene therapy trials under investigation Reuters
02:48PM  Top Gene-Sequencing Stocks for 2019 Motley Fool
09:21AM  3 Top Dividend Stocks to Buy Right Now Motley Fool
Apr-18-19 11:12PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
10:29AM  Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs Zacks
Apr-17-19 04:52PM  Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted Investor's Business Daily
02:34PM  Here's Why Ionis Pharmaceuticals Slumped Today Motley Fool
01:54PM  Why A Highly Rated Biotech With A 54% Gain This Year Is Being Gutted Investor's Business Daily
07:48AM  The Daily Biotech Pulse: Zolgensma Data, Roche Q1 Results, Brainsway IPO Benzinga
Apr-16-19 07:13PM  Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran Zacks
06:54PM  Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales Zacks
01:00PM  Marijuana ETF Down 9% in Past Month: Time to Enter the Space? Zacks
11:41AM  Allergan Falls as Supreme Court Dismisses Restasis Litigation Zacks
10:57AM  Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA Zacks
08:10AM  The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives Benzinga
Apr-15-19 04:49PM  Alnylam (ALNY) Reports Phase III ENVISION Data on Givosiran Zacks
06:00AM  Alcon Stock Is Back. The Eye-care Company Deserves a Long, Hard Look. Barrons.com
Apr-12-19 10:30AM  Pharma Stock Roundup: AZN, MRK, GSK Get Regulatory Approvals, Sandoz Inks New Deal Zacks
10:02AM  Ophthotech Gets Rights to Gene Therapy for BEST Disease Zacks
Apr-11-19 06:20PM  Novartis to Market Rizmoic Through Sandoz, Spins Off Alcon Zacks
03:33PM  Biotechnology Market on a Tear: 5 ETFs in Spotlight Zacks
02:46PM  Top Research Reports for McDonald's, Enterprise Products & Charles Schwab Zacks
10:03AM  Intercept Reports Additional Positive Data From NASH Study Zacks
06:45AM  Heres the Real Problem with Altria Overpaying for CRON Stock InvestorPlace
Apr-10-19 04:56PM  What Alcons Spinoff Can Teach Bausch Health Barrons.com
04:33PM  5 Companies Paying High Dividend Yields GuruFocus.com
11:12AM  Alcon Can See Clearly Now GuruFocus.com
10:16AM  Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval Zacks
09:44AM  Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug Benzinga
07:52AM  Q1 Cannabis Wholesale Report: Best-Selling Brands And Products, Pharma, CBD And Interstate Commerce Benzinga
Apr-09-19 05:06PM  What Happened in the Stock Market Today Motley Fool
01:23PM  Here's Why Novartis Is Sliding Today Motley Fool
11:45AM  Alcon Begins Trading After Spinoff From Novartis TheStreet.com
11:42AM  Novartis News: NVS Stock Sinks Following Alcon Spin-Off InvestorPlace
10:34AM  Alcon CEO on where the company is headed following spin-off from Novartis CNBC Videos
09:50AM  Alcon Stock Is Trading Strongly in Its U.S. Debut After the Novartis Spinoff Barrons.com
08:10AM  The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing Benzinga
04:12AM  Alcon tops $28 billion market cap in decade's biggest Swiss stock deal Reuters
04:09AM  Alcon tops $28 bln market cap in decade's biggest Swiss stock deal Reuters
02:39AM  Alcon seen valued up to $25 billion in biggest Swiss stock deal in decade Reuters
01:54AM  Top 5 Things to Know in The Market on Tuesday Investing.com
01:53AM  FirstFT: Todays top stories Financial Times
Apr-08-19 11:00PM  Novartis to limit M&A spend to 5% of market value Financial Times
10:37PM  Alcon/Novartis: eye inflection Financial Times
03:51PM  Eye-Care Leader Alcon Is About to Hit the Stock Market Barrons.com
10:37AM  Corcept (CORT) Rides High on Cushing's Syndrome Drug Korlym Zacks
09:41AM  The Zacks Analyst Blog Highlights: Pfizer, Teva, Novartis, Merck and AstraZeneca Zacks
07:48AM  Lawsuit over migraine deal could be good for Amgen, analysts say MarketWatch
Apr-07-19 06:31PM  Why Amgen's Giving Novartis a Headache Motley Fool
Apr-06-19 06:13PM  Should Biogen Investors Be Extra Nervous Right Now? Motley Fool
03:41AM  Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men Zacks
Apr-05-19 09:26PM  Pfizer's Ibrance Gets FDA Approval for Breast Cancer in Men Zacks
10:20AM  Pharma Stock Roundup: NVS Inks Immunology Deal, PFE, TEVA Get Drug Approvals in EU Zacks
10:14AM  Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig Zacks
09:33AM  Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine Deal Investor's Business Daily
08:44AM  The Zacks Analyst Blog Highlights: Amazon, 3M, Novartis, Schlumberger and ICICI Zacks
07:48AM  The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership Benzinga
Apr-04-19 05:16PM  Novartis, Amgen in dispute over migraine drug partnership Reuters
02:49PM  1 Biotech That Biogen Should Buy ... but Probably Won't Motley Fool
02:19PM  Top Analyst Reports for Amazon, 3M & Novartis Zacks
12:24PM  3 Ways to Buy Into the Marijuana Boom Without the Risk InvestorPlace
11:35AM  Novartis sues Amgen over migraine treatment Aimovig Reuters
10:23AM  Achillion Meets Enrollment Target in Kidney Disease Studies Zacks
09:39AM  Novartis Resubmits BLA to FDA for Biosimilar of Neulasta Zacks
07:26AM  Novartis CEO's $50 Billion of Deals Was Just the First Act Bloomberg
Apr-03-19 06:08PM  Biogen SMA drug price, Novartis estimates for its treatment far too high: U.S. group Reuters
05:41PM  Biogen SMA drug price, Novartis estimates for its treatment far too high -U.S. group Reuters
04:37PM  Biogen SMA drug price, Novartis estimates for its treatment far too high -U.S. group Reuters
10:02AM  After inking lease with cancer-fighting company, this new East Bay biotech project is full American City Business Journals
10:00AM  Allergan's AMD Drug Lowers Inflammation in Phase III Study Zacks
09:49AM  Roche Extends Offer Period for Spark Therapeutics Acquisition Zacks
08:19AM  The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings Benzinga
05:51AM  Novartis's Alcon spinoff ousts Baer from Swiss benchmark SMI Reuters
Apr-02-19 10:18AM  Novartis Gets Approval for Psoriasis Drug Cosentyx in China Zacks
09:36AM  Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe Zacks
07:30AM  The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial Benzinga
Apr-01-19 04:57PM  Novartis (NVS) to Acquire Subsidiary of IFM Therapeutics Zacks
04:38PM  Novartis Snags A $1.6 Billion Buy That Could Rival These Biotechs Investor's Business Daily
03:59PM  Novartis Announces $1.575B Acquisition Of IFM Tre Benzinga
01:29PM  Swiss drugmaker Novartis must face doctor kickback suit, U.S. judge rules Reuters
12:41PM  Novartis must face doctor kickback lawsuit, U.S. judge rules Reuters
07:02AM  BMOs Got A Point About Teva Stock, But Are Investors Willing To Listen? InvestorPlace
02:55AM  Novartis to pay $310 million for assets from inflammation specialist IFM Reuters
01:16AM  Novartis scoops up IFM immunotherapy subsidiary for $310 million American City Business Journals
Mar-31-19 11:01AM  2 Blockbuster Gene Therapy Programs to Watch in 2019 Motley Fool
Mar-30-19 12:00PM  3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop Motley Fool
Mar-27-19 06:13PM  Novartis (NVS) Receives FDA Approval for MS Drug Mayzent Zacks
04:30PM  Jazz's Xyrem Follow-On Drug Succeeds in Phase III Study Zacks
04:12PM  The Hits Just Keep Coming For Biogen As Rival Gains MS Drug Approval Investor's Business Daily
01:19PM  Novartis MS drug wins FDA's blessing amid scrutiny of $88k annual price Reuters
12:45PM  6 Gene Therapy M&A Targets On The Radar Benzinga
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, and established medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapy, metabolism, oncology, ophthalmic, pain, and respiratory areas; and finished dosage form anti-infective. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The company's Alcon segment offers intraocular lenses and equipment for cataract procedures; equipment, instruments, and devices for vitreoretinal surgeries; surgical equipment and diagnostic devices for refractive surgical procedures; and devices to treat glaucoma. It also provides viscoelastics, surgical solutions, diagnostic ophthalmic products, surgical packs, and other disposable products for cataract and vitreoretinal surgery. In addition, this segment offers contact lenses and ocular health products; over-the-counter ophthalmic products; eye drops for the temporary relief of ocular itching due to allergies; vitamins for ocular health; and iLux Device, a therapeutic device used to treat meibomian gland dysfunction. Novartis AG has collaboration agreements with Xencor; Surface Oncology; Ligand Pharmaceuticals, Inc.; Amgen; University of California, Berkeley; Bristol-Myers Squibb; IBM Watson Health; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; PEAR Therapeutics; Pfizer; Conatus Pharmaceuticals Inc.; and TRIO. The company was founded in 1895 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novartis Bioventures Ltd10% OwnerApr 15Sale0.9928,79428,5064,802,661Apr 15 09:26 PM
Novartis Bioventures Ltd10% OwnerApr 12Sale1.0430,90832,1444,831,455Apr 15 09:26 PM
Novartis Bioventures Ltd10% OwnerApr 11Sale1.0857,43862,0334,862,363Apr 15 09:26 PM
Novartis Bioventures Ltd10% OwnerApr 10Sale1.09140,230152,8514,919,801Apr 10 06:26 PM
Novartis Bioventures Ltd10% OwnerApr 09Sale1.0132,99133,3215,060,031Apr 10 06:26 PM
Novartis Bioventures Ltd10% OwnerApr 08Sale1.0227,52528,0765,093,022Apr 10 06:26 PM
Novartis Bioventures Ltd10% OwnerApr 05Sale1.0224,66125,1545,120,547Apr 05 05:14 PM
Novartis Bioventures Ltd10% OwnerApr 04Sale1.0147,90048,3795,145,208Apr 05 05:14 PM
Novartis Bioventures Ltd10% OwnerApr 03Sale0.9658,03355,7125,193,108Apr 05 05:14 PM
Novartis Bioventures Ltd10% OwnerApr 02Sale0.9751,75450,2015,251,141Apr 02 08:09 PM
Novartis Bioventures Ltd10% OwnerApr 01Sale0.95116,909111,0645,302,895Apr 02 08:09 PM
Novartis Bioventures Ltd10% OwnerApr 01Sale1.9020,61039,1592,079,394Apr 02 08:23 PM
Novartis Bioventures Ltd10% OwnerMar 29Sale1.85106,540197,0992,100,004Apr 02 08:23 PM
Novartis Bioventures Ltd10% OwnerMar 29Sale0.9163,10057,4215,419,804Apr 02 08:09 PM
Novartis Bioventures Ltd10% OwnerMar 28Sale0.9488,83583,5055,482,904Mar 28 05:16 PM
Novartis Bioventures Ltd10% OwnerMar 27Sale0.9950,74950,2425,571,739Mar 28 05:16 PM
Novartis Bioventures Ltd10% OwnerMar 26Sale1.01177,762179,5405,622,488Mar 28 05:16 PM
Novartis Bioventures Ltd10% OwnerMar 15Sale1.9243,80084,0962,206,544Mar 15 05:25 PM
Novartis Bioventures Ltd10% OwnerMar 14Sale1.8813,80025,9442,250,344Mar 15 05:25 PM
Novartis Bioventures Ltd10% OwnerMar 13Sale2.12132,738281,4052,264,144Mar 15 05:25 PM
Novartis Bioventures Ltd10% OwnerAug 20Sale2.3020,38846,8922,396,882Aug 22 04:34 PM
Novartis Bioventures Ltd10% OwnerAug 20Sale3.905,30020,6705,800,250Aug 22 04:07 PM
Novartis Bioventures Ltd10% OwnerAug 17Sale2.108,70018,2702,417,270Aug 20 05:12 PM
Novartis Bioventures Ltd10% OwnerAug 16Sale2.108,80818,4972,425,970Aug 20 05:12 PM
Novartis Bioventures Ltd10% OwnerAug 15Sale2.152,6355,6652,434,778Aug 16 04:18 PM
Novartis Bioventures Ltd10% OwnerAug 14Sale2.263,3007,4582,437,413Aug 16 04:18 PM
Novartis Bioventures Ltd10% OwnerAug 13Sale2.361,6003,7762,440,713Aug 14 05:05 PM
Novartis Bioventures Ltd10% OwnerAug 10Sale2.445,61513,7012,442,313Aug 14 05:05 PM
Novartis Bioventures Ltd10% OwnerAug 09Sale2.482355832,447,928Aug 10 04:29 PM
Novartis Bioventures Ltd10% OwnerAug 08Sale2.781,0002,7802,448,163Aug 10 04:29 PM
Novartis Bioventures Ltd10% OwnerAug 07Sale2.971,7395,1652,449,163Aug 08 04:21 PM
Novartis Bioventures Ltd10% OwnerAug 06Sale3.022,9428,8852,450,902Aug 08 04:21 PM
Novartis Bioventures Ltd10% OwnerAug 02Sale3.334,70215,6582,453,844Aug 06 04:22 PM
Novartis Bioventures Ltd10% OwnerAug 01Sale3.228,18126,3432,458,546Aug 02 04:33 PM
Novartis Bioventures Ltd10% OwnerJul 31Sale3.074,50013,8152,466,727Aug 02 04:33 PM
Novartis Bioventures Ltd10% OwnerJul 30Sale3.272,0006,5402,471,227Jul 31 04:16 PM
Novartis Bioventures Ltd10% OwnerJul 27Sale3.386,45821,8282,473,227Jul 31 04:16 PM
Novartis Bioventures Ltd10% OwnerJul 26Sale3.637,93728,8112,479,685Jul 27 04:21 PM
Novartis Bioventures Ltd10% OwnerJul 25Sale3.8412,46047,8462,487,622Jul 27 04:21 PM
Novartis Bioventures Ltd10% OwnerJul 24Sale4.117002,8772,500,082Jul 25 04:35 PM
Novartis Bioventures Ltd10% OwnerJul 23Sale4.2530,600130,0502,500,782Jul 25 04:35 PM
Novartis Bioventures Ltd10% OwnerJul 17Sale4.7112,50058,8752,531,382Jul 18 04:17 PM
Novartis Bioventures Ltd10% OwnerJul 16Sale5.153001,5452,543,882Jul 18 04:17 PM